XenTech Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
2ndary - Private
XenTech General Information
Description
Provider of patient-derived tumor xenograft models designed to foster therapeutic development in oncology. The company's models focus on the pre-clinical evaluation of oncology therapeutics by offering translational platforms, enabling doctors to avail of relevant tumor models, and addressing tomorrow's needs in preclinical oncology research.
Contact Information
Website
www.xentech.euCorporate Office
- 1-7 Imp. Alexis Trinquet
- 91000 Evry
- France
Corporate Office
- 1-7 Imp. Alexis Trinquet
- 91000 Evry
- France
XenTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Aug-2022 | Completed | Generating Revenue | |||
| 5. Grant | 16-Mar-2009 | Completed | Generating Revenue | |||
| 4. Seed Round | 31-Oct-2008 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2006 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Startup |
XenTech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
XenTech Patents
XenTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021508835-A | Method based on detection of rad51 phoci in tumor cells | Active | 21-Dec-2017 | ||
| JP-7324769-B2 | Methods based on detection of rad51 foci in tumor cells | Active | 21-Dec-2017 | ||
| AU-2018387831-A1 | Methods based on the detection of rad51 foci in tumor cells | Active | 21-Dec-2017 | ||
| AU-2018387831-B2 | Methods based on the detection of rad51 foci in tumor cells | Active | 21-Dec-2017 | ||
| CA-3086794-A1 | Methods based on the detection of rad51 foci in tumor cells | Pending | 21-Dec-2017 | G01N33/575 |
XenTech Signals
XenTech FAQs
-
When was XenTech founded?
XenTech was founded in 2006.
-
Where is XenTech headquartered?
XenTech is headquartered in Evry, France.
-
What is the size of XenTech?
XenTech has 37 total employees.
-
What industry is XenTech in?
XenTech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is XenTech a private or public company?
XenTech is a Private company.
-
What is XenTech’s current revenue?
The current revenue for XenTech is .
-
How much funding has XenTech raised over time?
XenTech has raised $794K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process